OCULAR THERAPEUTIX, INC
Develops hydrogel drug delivery therapies for eye diseases like wet AMD and glaucoma.
OCUL | NDAQ
Overview
Corporate Details
- ISIN(s):
- US67576A1007
- LEI:
- Country:
- United States of America
- Address:
- 15 CROSBY DRIVE, 1730 BEDFORD
- Website:
- https://www.ocutx.com/
- Sector:
- Manufacturing
- Industry:
- Manufacture of pharmaceuticals, medicinal chemical and botanical products
Description
Ocular Therapeutix, Inc. is an integrated biopharmaceutical company focused on the formulation, development, and commercialization of innovative therapies for diseases and conditions of the eye. The company is committed to redefining the treatment experience for patients with retinal diseases by aiming to reduce the therapeutic burden associated with current standards of care. Its core focus is on its proprietary hydrogel-based drug delivery technology. The lead product candidate, AXPAXLI™ (axitinib intravitreal hydrogel), is an investigational therapy in late-stage clinical development for the treatment of wet age-related macular degeneration (wet AMD). Ocular Therapeutix's pipeline also extends to other ophthalmic conditions, including glaucoma and ocular hypertension.
Unlock This Filing & Millions More
You're one step away from the data you need. Create a free account to instantly view this filing and get access to powerful research tools.
Filings
Automate Your Workflow. Get a real-time feed of all OCULAR THERAPEUTIX, INC filings delivered via API.
Market Data
Market Data Not Available
Financials & KPIs
Unlock Full Financials for OCULAR THERAPEUTIX, INC
This data is available as part of our premium data solutions. Contact our team for access.
Need More History? Access decades of standardized financials for OCULAR THERAPEUTIX, INC via our API.
Insider Transactions
| Date | Insider Name | Position | Type | Shares | Value |
|---|---|---|---|---|---|
| No insider transactions recorded for this company. | |||||
